AU Patent

AU2013290444B2 — Pharmaceutical compositions of (R)-1-(2,2-diflurorbenzo[d][1,3]dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl) cyclopropanecarboxamide and administration thereof

Assigned to Vertex Pharmaceuticals Inc · Expires 2018-04-26 · 8y expired

What this patent protects

A pharmaceutical composition comprising Compound 1, (

USPTO Abstract

A pharmaceutical composition comprising Compound 1, (

Drugs covered by this patent

Patent Metadata

Patent number
AU2013290444B2
Jurisdiction
AU
Classification
—
Expires
2018-04-26
Drug substance claim
No
Drug product claim
No
Assignee
Vertex Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.